Abstract:Key PointsMucosal barrier function consists of the combined effects of multiple extracellular and cellular processes that may be disrupted globally or in a targeted manner by physiological and pathophysiological stimuli. In the presence of an intact epithelium, mucosal permeability is primarily determined by tight junction barrier function.Intestinal epithelial cells mediate interactions between the mucosal immune system and luminal materials. The mechanisms by which these epithelia regulate and, conversely, are regulated by the immune system are therefore of crucial importance to mucosal homeostasis and disease.In vitro and in vivo studies have indicated that cytokines, including tumour necrosis factor, LIGHT (also known as TNFSF14), interferon-γ, interleukin-13 (IL-13) and IL-17 can modify epithelial barrier function by mechanisms that include new protein synthesis, membrane trafficking, kinase activation, cytoskeletal modulation and epithelial apoptosis. The contributions of these events to acute and chronic barrier regulation are distinct and may complement one another.Increased intestinal permeability is associated with inflammatory bowel disease but can also be present in healthy individuals. Mouse models confirm that intestinal barrier dysregulation alone is insufficient to cause disease, but they also show that enhanced tight junction permeability can accelerate disease onset and increase severity.In addition to activating pro-inflammatory events, intestinal barrier dysfunction initiates immunoregulatory processes. Defects in these processes may be a cause of inflammatory disease.Further investigation of pathways that integrate mucosal barrier function, or dysfunction, and immune regulation will lead to a better understanding of the mechanisms underlying these complex interactions and provide a rational basis for the development of more effective and targeted therapeutic interventions.

Nucleic Acids and Phospholipids Content in Subcellular Fractions of a Trans. plantable Sarcoma

Epithelial regulation of microbiota-immune cell dynamics

Regulation of Intestinal Barrier Function by Microbial Metabolites

Gut Microbiota and Intestinal Trans-Epithelial Permeability

Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function

Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection

Epithelial sensing of microbiota-derived signals

The role of mucosal barriers in human gut health

[Indications of antibiotherapy in digestive salmonellosis in newborn infants].

Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity

Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function

Intestinal barrier: Molecular pathways and modifiers

Intestinal Permeability, Inflammation and the Role of Nutrients

Going Beyond Exposure to Local News Media: An Information-Processing Examination of Public Perceptions of Food Safety

The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease

A 28Gbps reference-less VCO based CDR with separate proportional path technology in 65nm CMOS

Satisfaction with oral status among adult school-attending Saudi women with and without posterior fixed partial dentures.

Immune-epithelial interactions in host defense

Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Intestinal mucosal barrier function in health and disease